Recent Headlines
National Brain Tumor Society Opens New Funding Call for Its Oligodendroglioma Research Fund
Request for Applications seeks proposals for research on clinically relevant biomarkers for oligodendroglioma tumors, closes January 15, 2016. - December 18, 2015 - National Brain Tumor Society
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
NuvOx Pharma Receives FDA Orphan Drug Designation for Radiosensitizer for Glioblastoma
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-108 for treatment of Glioblastoma. Orphan status provides NuvOx with development and commercial incentives such as tax credits for qualified clinical testing and market exclusivity for 7 years after the marketing approval is granted. - December 07, 2015 - NuvOx Therapeutics
F2G Ltd Announces the Acceptance of F901318 to Participate in the EMA’s Adaptive Pathways Pilot Programme
F2G Ltd, a UK based antifungal drug discovery and development company, today announced that its novel systemic antifungal product F901318 has been accepted to participate in the European Medicines Agency’s (EMA) Adaptive Pathways pilot programme. Initiated in March 2014, the Adaptive... - December 03, 2015 - F2G Ltd
Update on Glycomics - Achieve Safe, Easy, and Accurate O-Glycan Analysis with BlotGlyco® O-Glycan Sample Preparation Kit
MoBiTec to launch Sumitomo's BlotGlyco® O-Glycan Sample Preparation Kit, a streamlined process for releasing and purifying O-glycans for detection by HPLC, LC-MS, and MALDI-TOF MS. - November 19, 2015 - MoBiTec GmbH
Successful Atlanta 8.5K Closes Event Season
Walkers and runners at the Nov. 7 Starry Night Atlanta 8.5K raised more than $120,000 to benefit the Pediatric Brain Tumor Foundation. More than 600 supporters gathered for the evening 8.5K at Centennial Olympic Park to honor local children with brain tumors, our Stars: Andrea, Anna, Ascher,... - November 12, 2015 - Pediatric Brain Tumor Foundation
PBTF, ABC2 Cofund Pediatric Brain Cancer Screening Research
The Pediatric Brain Tumor Foundation and ABC2 (Accelerate Brain Cancer Cure) are working together to fund the development of immunosignature-based blood tests for detecting, classifying and monitoring pediatric medulloblastoma over time. - November 04, 2015 - Pediatric Brain Tumor Foundation
RxGenesys, LLC. Validates Claims via Double Blind Independent Study by Princeton Consumer Research
RxGenesys Complete Skin Care System(R) Reduces Fine Lines and wrinkles by 56% and Improves Radiance, Elasticity and Moisture Levels After Eight Weeks. Watch the interview at: http://youtu.be/9RySXfUbm3s RxGenesys, a developer, manufacturer and marketer of state-of-the-art skin care, based on a... - October 30, 2015 - RxGenesys
New Sealed Tubing Ends from AdvantaPure(R) Reduce Operational Costs and Improve Efficiencies; Help to Maintain a Sterile and Closed Fluid Transfer System
Now available from AdvantaPure is its AdvantaFlex(R) biopharmaceutical grade tubing with pre-sealed ends. The ends maintain a closed, sterile fluid path system for sampling and storage uses in biopharma and pharmaceutical applications. Sealed Tubing Ends save time compared to sealing on site and reduce the need for expensive aseptic connectors. The Single-Use product is supplied gamma sterilized and ready for immediate use in both upstream and downstream applications. - October 29, 2015 - AdvantaPure
Pregmama Announces First Pregnancy in Its Pilot Clinical Trial to Treat Infertility in Women Over 35
Rolling back the clock on infertility - October 22, 2015 - Pregmama LLC
CHI to Host Roundtable Discussions at Optimizing Bioassays for Biologics Conference
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences - October 10, 2015 - Cambridge Healthtech Institute
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Northern California Motorcyclists Ride for Kids with Brain Tumors
Nearly 200 motorcyclists gathered for the Northern California Ride for Kids over the weekend to support children battling brain tumors. As of ride time, the family-friendly motorcycle event in Fairfield, Calif., had raised $59,342 to support the Pediatric Brain Tumor Foundation. The event honored... - October 07, 2015 - Pediatric Brain Tumor Foundation
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals
ELISA Biology Contract Research Services Provided by Altogen Labs
Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs
Regulate Gene Expression with Altogen Labs RNAi Technology
Ribonucleic Acid or RNA is a molecule critical to biology because it is behind the coding, regulation and expression of genes. With the RNA Interference or RNAi technology service offered by Altogen Labs it is possible to effectively regulate gene expression. Moreover, Altogen Labs has developed... - October 03, 2015 - Altogen Labs
Bostonians Walk, Run for Kids with Brain Tumors
About 200 Bostonians gathered on Sept. 26 for the Starry Night Boston 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $27,074 to help fund the foundation’s lifesaving research and life-changing family support programs. The crowd gathered for the... - September 30, 2015 - Pediatric Brain Tumor Foundation
Motorcyclists Contribute $167,000 to Aid Sick Children
From the Las Vegas Strip to the Capitol area, more than 700 motorcyclists gathered for children battling brain tumors over the weekend. As of ride time, the family-friendly Baltimore-Washington and Las Vegas Ride for Kids events had raised $167,459 to support the Pediatric Brain Tumor... - September 30, 2015 - Pediatric Brain Tumor Foundation
FDA Renews Pinnacle 21 as Software Provider for DataFit
Pinnacle 21 announced today that it has been selected to provide custom software and related services to support the FDA’s DataFit program, which serves to expedite the new drug application process. - September 26, 2015 - Pinnacle 21
MoBiTec GmbH to Attend BIOTECHNICA 2015, Germany - See ZDGSY's Inimitable GS-Key, an Amazingly Small and Fast DNA Extraction Device
BIOTECHNICA - Europe's No.1 Event for Biotechnology, Life Sciences, and Lab Technology! At MoBiTec's booth, cutting-edge technologies will be presented. Highlight: An incredibly small and fast handheld device for DNA extraction! - September 25, 2015 - MoBiTec GmbH
Philadelphia Athletes Complete 8.5k for Kids with Brain Tumors
The City of Brotherly Love welcomed about 750 walkers and runners on Sept. 19 for the Philadelphia Starry Night 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $47,974 to help fund the foundation’s lifesaving research and life-changing family... - September 23, 2015 - Pediatric Brain Tumor Foundation
Golden State Motorcyclists Ride for Kids with Brain Tumors
More than 330 motorcyclists gathered for children battling brain tumors at the San Diego Ride for Kids event over the weekend. As of ride time, this motorcycle event had raised $35,912 to support the Pediatric Brain Tumor Foundation. The event at Mira Costa College in Cardiff honored four local... - September 23, 2015 - Pediatric Brain Tumor Foundation
Marriage of Science and Marketing Makes Beautiful Skin Affordable
RxGenesys blends high-end stem cell tech with smart distribution and devoted customers to bring celebrity beauty secrets to real women -- on a budget. Less than three minutes and $1.50 a day visibly improve the skin’s appearance. When Sports Illustrated goddess Paulina Porizkova burst onto... - September 21, 2015 - RxGenesys
Miami-Based RxGenesys, LLC Raises 4 Million in Series B Funding
With funding and proven results, RxGenesys has partnered with marketing mogul and Shark Tank celebrity Kevin Harrington, who will spearhead the company’s Direct Response Campaign. “I’ve seen a lot of products and a lot of business plans, I joined the RxGenesys initiative because a direct response strategy using a prestige product like this is fresh and absolutely ideal to capture the growing market for products that look and feel like a celebrity insider secret,” Harrington said. - September 21, 2015 - RxGenesys
MoBiTec to Offer ProteoGREEN™-gGlu, a Fluorogenic Probe for Specific Detection of Cancer Cells
ProteoGREEN™-gGlu is a cancer-selective fluorogenic imaging probe that is rapidly activated to a highly fluorescent compound. The membrane-permeable dye is suitable for live cells or in vivo imaging of cancer cells. - September 18, 2015 - MoBiTec GmbH
MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company
Motorcyclists from Coast to Coast Ride for Kids with Brain Tumors
Motorcyclists from Birmingham, Philadelphia and Puget Sound hit the road for children battling brain tumors during Ride for Kids events over the weekend. These family-friendly motorcycle events, held in Leeds, Ala., Phoenixville, Pa., Carnation, Wash., raised more than $150,000 to support the... - September 16, 2015 - Pediatric Brain Tumor Foundation
Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener™ Epigenetic Methylation Test
The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive methyltransferase inhibitors from small-molecule chemical libraries. - September 10, 2015 - Cayman Chemical Company
NanoCellect and UCSD Team Up on Single-Cell Sorting and Analysis
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life science researchers, begins a collaboration with UCSD to develop single cell applications based on their WOLF Cell Sorter. The WOLF Cell Sorter enables easy-to-use cell sorting that... - September 02, 2015 - NanoCellect
VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend
The Cognitive Health Online Summit will occur on September 2, 2015, and will feature Philip Bromley discussing Smart Delivery Technologies. VIRUN signs a lease for a new R&D facility in Pomona, California. SupplySide West Expo 2015 is right around the corner, and VIRUN is sure to be a crowd pleaser as it goes back in time to deliver the future of functional beverages. VIRUN has added a “Shop VIRUN” page to proliferate the VIRUN phenomenon. - September 01, 2015 - VIRUN
KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC
Keynote Line-Up and Seven FDA Speakers Confirmed for Immunogenicity and Bioassay Summit 2015, Organized by Cambridge Healthtech Institute
Seventh annual event to focus on technologies and strategies for safe and efficacious products in the clinic. - August 31, 2015 - Cambridge Healthtech Institute
Ambu Partners with ValueCentric in Data Enhancement Initiative
Ambu chooses ValueCentric for their expertise in data cleansing and enhanced Master Data Management services. - August 27, 2015 - ValueCentric
New England, North Carolina Motorcyclists Hit Road for Kids
From the mountains of North Carolina to history-rich sites of Massachusetts, motorcyclists hit the road over the weekend for kids battling brain tumors. These family-friendly Ride for Kids events, held in Asheville, N.C., and Framingham, Mass., raised $84,236 to support the Pediatric Brain Tumor... - August 27, 2015 - Pediatric Brain Tumor Foundation
Molecular Innovations, Inc. Issued U.S. Patent for Human Prorenin ELISA Kit
Molecular Innovations, Inc. has been issued United States Patent Number 9,085,795 for its unique and novel “Human Prorenin ELISA Kit.” - August 23, 2015 - Molecular Innovations
AdvantaPure(R) Welcomes Mark Mistretta as East Coast Sales Manager; Brings Sales and Engineering Experience to Assist Customers with Process System Integration
AdvantaPure announces the appointment of Mark Mistretta to its team. Mistretta fills the east coast sales position vacated due to the recent promotion of another team member. His experience in sales and mechanical engineering will help AdvantaPure’s Single-Use system customers work out their biopharma fluid flow concepts and application challenges. As Eastern Regional Sales Manager, Mistretta is responsible for the management and growth of accounts in the eastern U.S. - August 21, 2015 - AdvantaPure
St. Louis Motorcyclists Rev It Up at Ride for Kids
St. Louis motorcyclists gathered over the weekend to honor 11 local brain tumor survivors at the Pediatric Brain Tumor Foundation's Ride for Kids event. The family-friendly event, held at St. Charles Community College in Cottleville, raised $46,290 to support the foundation's lifesaving research... - August 19, 2015 - Pediatric Brain Tumor Foundation
Concept Life Sciences Acquires CXR Biosciences to Augment Its Expanding Service Base in Discovery and PreClinical Sciences
Concept Life Sciences, scientific Laboratory and consultancy group has acquired CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life Sciences Group currently has over 600... - August 18, 2015 - Concept Life Sciences
Eurogentec (EGT), Belgium, Appoints MoBiTec GmbH as Distributor for Germany
Eurogentec (EGT) is a leading provider of innovative products and services to the life science, diagnostic, and pharmaceutical community. MoBiTec is selling the products of AnaSpec, which now is part of EGT, for more than 10 years already. The agreement allows MoBiTec to also offer EGT's state-of-the-art qPCR kits, oligonucleotides, and further products related to genomics to its customers. - August 14, 2015 - MoBiTec GmbH
KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
Pinnacle 21 CEO Max Kanevsky Named to PharmaVOICE 100
Pinnacle 21 announced today that its president & CEO, Max Kanevsky, has been named to the prestigious PharmaVOICE 100 list of the most innovative and influential people in the life-sciences industry. - August 07, 2015 - Pinnacle 21
Vitamin Weed: Get Healthy, Not High: Big Brother Star Launches Crowdfunding Campaign for Cannabis Book
Dr. Michele Noonan Ross plans to educate both patients and doctors with her new book Vitamin Weed: Get Healthy, Not High, a revolutionary 4-step plan to reversing endocannabinoid deficiency and restoring balance to your body. Launching July 22nd on the Publishizer crowdfunding platform, 10% of book sales will be donated to the Endocannabinoid Deficiency Foundation to directly fund cannabinoid research. - August 06, 2015 - GreenStone Labs
Motorcyclists in Three States Help Children with Brain Tumors
Ride for Kids motorcyclists gathered in three states over the weekend and raised $103,927 for the Pediatric Brain Tumor Foundation. The events in Michigan, New York and Pennsylvania honored 25 local brain tumor survivors on Aug. 2: Andrea, Andrew, Angel, Annabelle, Bo, Catie, Gianna, James, Jon,... - August 05, 2015 - Pediatric Brain Tumor Foundation
Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech
Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015 - Braasch Biotech LLC
Riders in Midwest, South Raise Funds for the PBTF
From the southern hills to the Midwestern plains, Ride for Kids motorcyclists combined to raise more than $90,000 for the Pediatric Brain Tumor Foundation on July 26. More than 300 participants attended the East Tennessee and Kansas City Ride for Kids events to honor their local brain tumor... - July 29, 2015 - Pediatric Brain Tumor Foundation
MiTeGen Announces Mutual Distribution Agreements with Rigaku Reagents
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with Rigaku Reagents. - July 23, 2015 - MiTeGen, LLC
Drip & Prep – RNA Isolation Has Never Been so Easy; FortiusBio LLC do Cell Lysis Cards to the Utmost
MoBiTec GmbH's new partner FortiusBio LLC is a US startup biotech firm that does only one thing good: to soak filter paper with proprietary lysis solutions and make cards which lyse cells and preserve nucleic acid (even RNA) integrity at room temperature. - July 22, 2015 - MoBiTec GmbH
Ride for Kids Crosses Borders to Raise Funds for PBTF
Ride for Kids motorcyclists rode in three states to raise $392,428 for the Pediatric Brain Tumor Foundation over the weekend. Riders in Minnesota, New York and Wisconsin honored 27 brain tumor survivors on July 19: Alyona, Amanda, April, Beckett, Carra, Catrina, Connor, Dominic, Emily, Hunter,... - July 22, 2015 - Pediatric Brain Tumor Foundation